Title
Category
Credits
Event date
Cost
ALAHOPE Recorded Course - Neuromechanisms of Substance Use Disorder
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 ACPE Technician
  • 0.25 ABO
  • 0.25 ABP
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the neurology and neurobiology components of substance use disorder along with explaining the similarities between substance use disorder and chronic disease.
ALAHOPE Recorded Course - Substance Use Disorder Assessment, Diagnosis, and Risk Factors
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 ABO
  • 0.25 ABP
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session explaining the assessment, diagnosis, and risk factors of substance use disorder.
ALAHOPE Recorded Course - Multidisciplinary and Patient Centered Approach to Substance Use Disorder
  • ALAHOPE Substance Use
  • 0.30 ABN
  • 0.25 ABSWE
  • 0.25 ACPE Pharmacy
  • 0.25 ACPE Technician
  • 0.25 ABO
  • 0.25 ABP
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 Attendance
  • 0.25 BDEA
$0.00
An interactive, online training session regarding the importance of taking a multidisciplinary, patient centered approach to substance use disorder treatment.
ALAHOPE Recorded Course - Pharmacologic Treatment for Substance Use Disorder and Related Conditions
  • ALAHOPE Substance Use
  • 0.60 ABN
  • 0.50 ABSWE
  • 0.50 ACPE Pharmacy
  • 0.50 ACPE Technician
  • 0.50 ABO
  • 0.50 ABP
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
  • 0.50 BDEA
$0.00
An interactive, online training session regarding treating opioid use disorder with FDA approved medications along with common challenges found during such treatment.
Advancing Tobacco and Nicotine Cessation Strategies for Low Socioeconomic Communities in Alabama
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BDEA
09/26/2025
$0.00
This webinar will provide information for primary care providers and pharmacies on how to help patients quit smoking and vaping.
Recent Updates for the Management of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
11/11/2025
$0.00
Urinary tract infections (UTIs) are one of the most common infectious diseases in the outpatient, long-term care, and inpatient settings.  In 2025, new treatment guidelines were released that updated the definitions for uncomplicated urinary tract infections (uUTIs) from complicated UTIs (cUTIs), as well as updated the treatment recommendations for cUTIs, such as pyelonephritis.  Healthcare providers must be familiar with these new recommendations to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship to minimize the developm
ENCORE - Recent Updates for the Management of Urinary Tract Infections
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
11/13/2025
$0.00
Urinary tract infections (UTIs) are one of the most common infectious diseases in the outpatient, long-term care, and inpatient settings.  In 2025, new treatment guidelines were released that updated the definitions for uncomplicated urinary tract infections (uUTIs) from complicated UTIs (cUTIs), as well as updated the treatment recommendations for cUTIs, such as pyelonephritis.  Healthcare providers must be familiar with these new recommendations to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship to minimize the developm
Recent Updates for the Management of Community-Acquired Pneumonia
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
12/04/2025
$0.00
Community-acquired pneumonia (CAP) is one of the most common infectious diseases encountered in both the inpatient and outpatient settings.  Additionally, it is a significant cause of both morbidity and mortality.  Clinical practice guidelines for the treatment of CAP were published in 2019, and in 2025, a focused update to these guidelines was released, which focused on four primary questions.  Healthcare providers must be familiar with both the 2019 and 2025 guidelines to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship
ENCORE Recent Updates for the Management of Community-Acquired Pneumonia
  • Improving Antimicrobial Stewardship Across Alabama (IASAA)
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
12/09/2025
$0.00
Community-acquired pneumonia (CAP) is one of the most common infectious diseases encountered in both the inpatient and outpatient settings.  Additionally, it is a significant cause of both morbidity and mortality.  Clinical practice guidelines for the treatment of CAP were published in 2019, and in 2025, a focused update to these guidelines was released, which focused on four primary questions.  Healthcare providers must be familiar with both the 2019 and 2025 guidelines to provide the best treatment possible for patients while simultaneously providing appropriate antimicrobial stewardship

Pages